HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.
White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.
Henry Brem Named Director Of Neurology At Johns Hopkins.
Cancer Groups Oppose Plan To Cut Drug Reimbursement.
Edward Benz Named President Of Dana-Farber Cancer Institute.
Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.
75% Of Fed Research Funds Pay Direct Costs, Study Says.
More Women Over 50 Report Having Had Mammograms.
US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.
FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.
Sweden Approves Photofrin For Palliation Of Two Cancers.
Firm Buys Rights To NKT Cells From Beth Israel Deaconess.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
